Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
Unusual multisystemic relapse of sarcoidosis after corticosteroids withdrawal Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
Choroidal granuloma presenting during anti-tuberculous chemotherapy administration Source: Eur Respir J 2006; 28: Suppl. 50, 26s Year: 2006
Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015
Corticosteroid treatment in sarcoidosis Source: Eur Respir J 2006; 28: 627-636 Year: 2006
Therapy with low dose methotrexate plus diprospan in patient with recalcitrant recidivating sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 541s Year: 2006
Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Immunoallergic manifestations of antituberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 505s Year: 2006
Pulmonary vasculitis: update on the management of ANCA-associated vasculitis Source: Eur Respir Mon; 2009: 46: 251–264 Year: 2009
Combined immunosuppressive therapy including anti-TNFα in a treatment of severe paediatric sarcoidosis – a case report Source: Eur Respir J 2006; 28: Suppl. 50, 829s Year: 2006
Rituximab in the treatment of refractory pulmonary sarcoidosis Source: Eur Respir J 2014; 43: 1525-1528 Year: 2014
Anti-TNF-alpha therapy in patients with latent tuberculosis incidence Source: International Congress 2015 – Screening strategies in TB Year: 2015
Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab Source: Eur Respir J 2006; 27: 644-646 Year: 2006
Pulmonary manifestations of systemic vasculitis in childhood Source: Breathe, 16 (4) 200211; 10.1183/20734735.0211-2020 Year: 2020
Diagnosis, course and management of hypersensitivity pneumonitis Source: Eur Respir Rev, 31 (163) 210169; 10.1183/16000617.0169-2021 Year: 2022
Therapeutic options for sarcoidosis: old and new Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005 Year: 2005
Safety and efficacy of prolonged treatment of fibrosing alveolitis in scleroderma with cyclophosphamide Source: Eur Respir J 2005; 26: Suppl. 49, 266s Year: 2005
Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment Source: International Congress 2015 – Latent TB infection and screening Year: 2015
Unusual presentation of pulmonary nocardiosis as pyopneumothorax in a patient under corticotherapy Source: International Congress 2019 – Interstitial lung diseases? Year: 2019
Treatment of patients with extensive TB and concomitant bronchial lesions with some anti-TB drugs delivered via nebulizer Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013